2 results match your criteria: "University Clinic for Oncology and Haematology[Affiliation]"
Emerging role of bevacizumab in management of patients with symptomatic hepatic involvement in Hereditary Hemorrhagic Telangiectasia.
Am J Hematol
November 2017
University Clinic for Oncology and Haematology, Klinikum Oldenburg, Germany.
Background: Early detection and improved (neo)-adjuvant treatment has extended survival of breast cancer over the last decades. It remains controversial whether a survival benefit is achieved once metastases have occurred. This study investigates survival trends in metastatic breast cancer (MBC) looking at the distribution of prognostic factors and the time period of the diagnosis of the primary and metastatic disease.
View Article and Find Full Text PDF